BioScrip to Present at BMO Capital Markets 10th Annual Focus on Healthcare Conference

ELMSFORD, N.Y.--(BUSINESS WIRE)--BioScrip, Inc. (Nasdaq: BIOS) today announced that it will present at the BMO Capital Markets 10^th Annual Focus on Healthcare Conference on Thursday, August 5, 2010 at the Sheraton New York Hotel & Towers in New York City.

BioScrip's Chairman and Chief Executive Officer, Richard H. Friedman, and Richard M. Smith, President and Chief Operating Officer will present at 11:15 AM ET (Eastern Time). Investors may access a live audio web cast of BioScrip's presentation at the following link: http://www.bmocm.com/conferences/2010healthcare/webcast/. A web cast replay of the presentation can also be accessed via BioScrip’s website at www.bioscrip.com, under the “Investors Section”.

About BioScrip, Inc.

BioScrip, Inc. (www.bioscrip.com) (Nasdaq: BIOS) is a national provider of specialty pharmacy and home care products and services that partners with patients, physicians, hospitals, healthcare payors and pharmaceutical manufacturers to provide clinical management solutions and delivery of cost-effective access to prescription medications. Our services are designed to improve clinical outcomes for chronic and acute healthcare conditions while controlling overall healthcare costs.

Forward Looking Statements-Safe Harbor

This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company, Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. Important factors that could cause such differences are described in the Company’s periodic filings with the Securities and Exchange Commission.